›› Dr. Doris Browne | back to Medical Advisory Board

Dr. Doris Browne is also President and CEO, Browne and Associates, Inc., a health consultancy company, which manages diversified health programs that address the health status and disparities of national and international populations through the use of health information and communication technologies to enhance positive health outcomes. Browne and Associates’ activities are primarily focused in the areas of breast and prostate cancers, women's health, disaster management, HIV/AIDS and other infectious diseases with emphasis on health promotion and disease prevention. Dr. Browne recently retired (2009) from the National Cancer Institute where she managed the breast cancer portfolio for the Breast and Gynecologic Cancer Research Group in the Division of Cancer Prevention.  Her primary focus was centered on the development of chemoprevention agents for breast cancer and the identification of surrogate endpoint biomarkers.  She is also a Woodrow Wilson Public Policy Scholar (2007) at the Woodrow Wilson International Center for Scholars where her research focused on estrogen receptor negative breast cancer health disparities. Dr Browne is a retired Colonel of the US Army Medical Corps and former Director, Medical Research and Development, US Army Medical Research and Materiel Command where she was responsible for the biomedical research programs for the Army and the Department of Defense (DoD).  Previously, Colonel Browne was Director, Prevention and Standards, Office of the Assistant Secretary of Defense for Health Affairs with responsibility for analysis, review, and formulation of policies, guidelines and programs on women's health issues, oversight for health promotion and disease prevention, and TRICARE preventive benefits.  She served as Chairperson, DoD Breast Cancer Prevention, Education, and Diagnosis Initiative and DoD’s representatives to the National Action Plan on Breast Cancer.